These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33017380)

  • 21. Retrospective analyses of optical coherence tomography in recurrent macular edema following intravitreal therapy in patients with retinal vein occlusion.
    Holland SM; Dodwell DG; Krimmel DA; de Fiebre CM
    BMC Ophthalmol; 2015 Sep; 15():117. PubMed ID: 26337708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. THE OMAR STUDY: Comparison of Ozurdex and Triamcinolone Acetonide for Refractory Cystoid Macular Edema in Retinal Vein Occlusion.
    Ozkok A; Saleh OA; Sigford DK; Heroman JW; Schaal S
    Retina; 2015 Jul; 35(7):1393-400. PubMed ID: 25748280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bevacizumab and Ranibizumab for macular edema due to retinal vein occlusions].
    Niederhauser N; Valmaggia C
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):405-8. PubMed ID: 23629792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion.
    Bakri SJ; Omar AF
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):547-9. PubMed ID: 22537269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of Intravitreal Corticosteroid with Anti-vegf in Macular Edema Secondary to Retinal Vein Occlusion.
    Valašková J; Popov I; Krásnik V
    Cesk Slov Oftalmol; 2018; 73(5-6):183-188. PubMed ID: 30541298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.
    Cekiç O; Cakır M; Yazıcı AT; Alagöz N; Bozkurt E; Faruk Yılmaz O
    Curr Eye Res; 2010 Oct; 35(10):925-9. PubMed ID: 20858114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion.
    Kim JY; Park SP
    Korean J Ophthalmol; 2009 Dec; 23(4):259-65. PubMed ID: 20046685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.
    Tang F; Qin X; Lu J; Song P; Li M; Ma X
    Retina; 2020 Apr; 40(4):773-785. PubMed ID: 30640282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the Effectiveness of Treatment with Dexamethasone Intravitreal Implant in Cystoid Macular Edema Secondary to Retinal Vein Occlusion.
    Donati S; Gandolfi C; Caprani SM; Cattaneo J; Premoli L; Azzolini C
    Biomed Res Int; 2018; 2018():3095961. PubMed ID: 30175123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.
    Iturralde D; Spaide RF; Meyerle CB; Klancnik JM; Yannuzzi LA; Fisher YL; Sorenson J; Slakter JS; Freund KB; Cooney M; Fine HF
    Retina; 2006 Mar; 26(3):279-84. PubMed ID: 16508427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4.
    Scott IU; VanVeldhuisen PC; Ip MS; Blodi BA; Oden NL; King J; Antoszyk AN; Peters MA; Tolentino M;
    JAMA Ophthalmol; 2017 Jun; 135(6):639-649. PubMed ID: 28492860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectral domain OCT documented resolution of recalcitrant macular edema after intravitreal bevacizumab in branch retinal vein occlusion.
    Chalam KV; Keshavamurthy R; Brar VS
    Eur J Ophthalmol; 2008; 18(5):831-3. PubMed ID: 18850569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.
    Kim M; Jeong S; Sagong M
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous intravitreal dexamethasone and aflibercept for refractory macular edema secondary to retinal vein occlusion.
    Giuffrè C; Cicinelli MV; Marchese A; Coppola M; Parodi MB; Bandello F
    Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):787-793. PubMed ID: 31897703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Off label intravitreal Brolucizumab in treatment of recurrent macular edema due to branch retinal vein occlusion: A case report.
    Panigrahi PK
    Photodiagnosis Photodyn Ther; 2022 Mar; 37():102694. PubMed ID: 34921989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of Age on Dexamethasone Intravitreal Implant (Ozurdex®) Response in Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Altunel O; Göktaş A; Duru N; Özköse A; Arifoğlu HB; Ataş M
    Semin Ophthalmol; 2018; 33(2):179-184. PubMed ID: 27599562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of immediate versus deferred intravitreal Bevacizumab in macular oedema due to branch retinal vein occlusion: a pilot study.
    Khan MA; Mallika V; Joshi D
    Int Ophthalmol; 2018 Jun; 38(3):943-949. PubMed ID: 28432581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension.
    Theodoropoulou S; Ellabban AA; Johnston RL; Cilliers H; Mohamed Q; Sallam AB
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):725-732. PubMed ID: 27878430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EFFICACY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR REFRACTORY MACULAR EDEMA CAUSED BY RETINAL VEIN OCCLUSION.
    Hussain RM; Ciulla TA; Ciulla LM; Sink B; Harris A
    Retin Cases Brief Rep; 2018 Fall; 12(4):294-299. PubMed ID: 27984545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.